John W. Childs - 04 Mar 2025 Form 4/A - Amendment Insider Report for Biohaven Ltd. (BHVN)

Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
4/A - Amendment
Accepted by SEC
09 Mar 2026, 18:12:05 UTC
Original report date
05 Mar 2025
Prior SEC filing
31 Dec 2024
Next SEC filing
07 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ George Clark, Attorney-in-Fact

Key filing fact

John W. Childs filed Form 4/A - Amendment for Biohaven Ltd. (BHVN) on 09 Mar 2026.

Key facts

  • This page summarizes John W. Childs's Form 4/A - Amendment filing for Biohaven Ltd. (BHVN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 09 Mar 2026, 18:12.

Change

  • Previous filing in this sequence was filed on 31 Dec 2024.
  • Current net transaction value: +$864,115.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001027035 Primary reporting owner

CHILDS JOHN W

Relationship
Director
Address
C/O BIOHAVEN LTD., 215 CHURCH STREET, NEW HAVEN
Signature
/s/ George Clark, Attorney-in-Fact
Signature date
09 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BHVN transaction

Common Shares

Purchase

Transaction value
$864,115
Shares
+28,400
Change %
+1.2%
Price
$30.43
Shares after
2,323,971
Date
04 Mar 2025
Ownership
By John W Childs 2013 Revocable Trust
Footnotes
F1, F2
BHVN holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
73,170
Date
04 Mar 2025
Ownership
By 2013 Charitable Remainder Trust
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on March 5, 2025 (the "Original Form 4"). The Original Form 4 inadvertently misstated that 3,400 Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust, and 25,000 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust. However, as reflected in this amendment, 28,400 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust, and no Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .